Friday, March 13, 2015

Guest blog: A Lawyer Walks Into the Doctor's Office









A Lawyer Walks Into the Doctor’s Office…
By Susan Jones Knape, Communications Director at Baron and Budd

We’d like to imagine that working with countless individuals who were hurt by fluoroquinolones has helped shield us to the dangers of these drugs, as if we could steer ourselves far away from fluoroquinolones like Avelox, Cipro and Levaquin altogether.

Unfortunately, “FLQ” antibiotics are so frequently prescribed, none of us can escape them … not even those of us who are acutely aware of their dangers.

In fact, this winter many of our team members were prescribed fluoroquinolones for very minor, routine infections. First there was the paralegal who had an ear infection. Then there was the lawyer with a UTI. Then someone had a skin infection.

Each time, our team members had the insight to say “no thanks” to the prescribing doctors and ask for a different medicine.

But what about people who don’t have the deep knowledge we have about these antibiotics?

They are at risk.

Despite the known associated dangers of FLQ drugs, we believe that far too many people are taking these antibiotics for everyday infections. We acknowledge the potential benefit and use of antibiotics like Cipro, Levaquin and Avelox for some life-threatening infections. The risk of nerve damage may very well outweigh the risk of a rampant infection in these cases. But for a minor infection in an otherwise healthy person? We know there are other antibiotics on the market that can fight the infection without risking permanent nerve damage.

Until more doctors and patients are made aware of the dangers associated with taking fluoroquinolone antibiotics — and until the manufacturers of these antibiotics respond appropriately to their associated risks and adjust the drug’s labeling and marketing — we must all be extra aware of the risks.

That may be easy on a day when you’re feeling fine. But when you’ve come down with a fever and your cough just won’t go away… it’s easy to fill a prescription without thinking twice. Those are the days when we have to be on guard. Because a fluoroquinolone antibiotic can be prescribed to anyone — and, sadly, today, for almost any bacterial infection.

One day, FLQ toxicity will be a thing of the past. Until then, we’re with you here at Baron and Budd. We want to do our part to help educate people and to fight back against the overuse of these drugs by zealous manufacturers.

Wednesday, March 11, 2015

QVF honors Progressive Medical Center





Quinolone Vigilance Foundation honors Progressive Medical Center for all their hard work on behalf of fluoroquinolone patients. Progressive Medical Center specifically treats Fluoroquinolone Toxicity, among other conditions. QVF works very closely with them so that their patients can receive the very best care possible. Pictured are Medical Director Dr. Gez Agolli, and Special Projects and Marketing Director Carey Spurgeon. 

www.progressivemedicalcenter.com  


Kansas City news story








Quinolone Vigilance Foundation's Raymore, Missouri Ambassador Chris Butler was interviewed for a news story which aired on March 10, 2015 on KCTV Kansas City. We thank Mr. Butler for arranging the interview.

Sunday, March 8, 2015

March Movement and Upcoming Projects



March has been a very busy and productive month for QVF.


Quinolone Vigilance Foundation and Executive Director Rachel Brummert are finalists for three WEGO Health Activist Awards. Winners will be announced at a ceremony on Wednesday, March 18. Thank you to everyone who nominated and endorsed us. We would not be here without you. It is an honor for us to be recognized with the other amazing activists in each category.

1. Best in Show: Twitter
2. Best Team Performance.
3. Best Kept Secret.





On March 13, QVF is holding a fundraiser at the Grog & Tankard in Stafford, Virginia.





Quinolone Vigilance Foundation wishes to thank the  Grog And Tankard Sports Bar & Grill, Dark Anubis Promotions, and the bands  ZFL, Helafyde, Echoes of Solitude, goddess Crow, and Service of Shadows for making this possible. We look forward to an awesome show.


Admission is:
18+ $15
21+ $10

If you are unable to attend the show, you can still support us:

1. PayPal- donations@saferpills.org


2. Check or money order to:
Quinolone Vigilance Foundation
9817 Stephen Thompson Lane
 Charlotte, NC 28213

Donations are tax deductible.

Quinolone Vigilance Foundation is a non-profit 501(c)(3) charitable organization which fosters, initiates, and funds vital research into Fluoroquinolone Toxicity. We also raise awareness about the dangers of fluoroquinolone antibiotics such as Levaquin, Cipro, and Avelox. In addition, we educate doctors about the dangers to their patients, and we help medical facilities re-write their policies on how they are prescribed.

At QVF we do not take a salary and overhead expenses are paid out of our own pockets. Donations go to helping us further our mission.

To quote our mission statement:

"To fulfill the Mission, we will:

-Network medical professionals and researchers.
- Foster, initiate, and direct fundamental research to discover underlying toxicity mechanisms.
- Fund research that will produce the most promising results.
- Translate new discoveries into effective medical practices, therapies and public health approaches.
- Develop and apply discovered knowledge to educate the medical community and help alleviate individual suffering."

This event is dedicated to the memories of Chris Dannelly and Bob Grozier, who tragically lost their lives after taking Levaquin and Cipro respectively. The flyers will have photos of the men with some information about them. We thank the Dannelly and Grozier families for providing the photos to us and for allowing us to tell their stories to the patrons to everyone in attendance.

We will have wristbands, awareness poster, flyers, photo album, brochures, awareness cards, and other items.








For more information:
http://quinolonevigilancefoundation.blogspot.com/2015/02/qvf-fundraising-event.html


We will post photos during and after the event.




On March 26, Executive Director Rachel Brummert will be speaking at a Congressional Hearing on Capitol Hill.


The following day on March 27 she will give testimony at an FDA Hearing about a proposed rule that would serve to overturn the Pliva. v Mensing Supreme Court decision which currently prevents generic drug makers from being sued for the damage generic medications cause.







Ms. Brummert will urge Congressional leaders and the FDA to finalize the proposed rule as written because it will promote safety by holding generic drug manufacturers accountable, and stress that delaying this measure will lead to further harm.

Quinolone Vigilance Foundation is honored to be working with the American Association for Justice on this project.


For more information on how you can help: http://quinolonevigilancefoundation.blogspot.com/2015/03/executive-director-rachel-brummert.html


QVF is also working with a news station about the work we do. We are not releasing further information until something solid is in place.



We are also pleased to announce that Quinolone Vigilance Foundation has the support of three Attorneys General on an upcoming project. We are not releasing specifics at this time to protect the integrity of the project. It will take a long time  for this to come to fruition so please bear with us.


We are also pleased to announce that we are working with a Governor to raise awareness about Fluoroquinolone Toxicity. We are not releasing details at this time. Approximate completion of this project will be winter of 2015.


As always, thank you for supporting Quinolone Vigilance Foundation and trusting us to be your voice.
















Friday, March 6, 2015

Executive Director Rachel Brummert testifying at FDA Hearing

UPDATE: March 16, 2015 6:08PM EST. We were just informed by the American Association for Justice that there will not be time for us to speak at the Congressional Hearing on March 26. We will, however, be testifying at the FDA Hearing on March 27. We apologize for any inconvenience.; this was beyond our control.


In August 2014, Baron & Budd Law Firm filed the first round of state and federal lawsuits on behalf of victims who have been injured after taking a brand name fluoroquinolone (Levaquin, Cipro, Avelox). Click here for more information.

Because of a 2010 Supreme Court decision- Pliva v Mensing- victims who took a generic fluoroquinolone could not be included in the lawsuits. It was frustrating and unjust, but the attorneys who are taking cases have to work within the confines of the law and their hands, at the moment, are tied.

Wouldn't it be great if there was a way to get Pliva v Mensing overturned?

Now there is.

Quinolone Vigilance Foundation Executive Director Rachel Brummert will be speaking at a Congressional hearing on Capitol Hill on March 26.



The following day on March 27 she will give testimony at an FDA Hearing about a proposed rule that would serve to overturn the Pliva. v Mensing Supreme Court decision which currently prevents generic drug makers from being sued for the damage generic medications cause.




Ms. Brummert will urge Congressional leaders and the FDA to finalize the proposed rule as written because it will promote safety by holding generic drug manufacturers accountable, and stress that delaying this measure will lead to further harm.

What can you do to help?

Unfortunately, the American Association for Justice is no longer accepting recommendations for speakers at the FDA Hearing and speakers have already been chosen.

However, the most important thing people can do is click here to submit Public Comments on the FDA website. On the right hand side, you’ll see a button that says “Comment Now” and you can either write it there, copy and paste it there, or attach a document you have already written. Comments will be included in the decision as to whether the rule will pass.





Some guidelines to consider when submitting your Public Comments:

Your story can be as short or as long as you like.  We also encourage you to make a statement at the end of your story that includes the following bullet points, but in your own words:
  • As someone with first-hand generic drug experience
  • The FDA should finalize the proposed rule as written
  • The proposed rule warns of hazards of taking generic drugs
  • The proposed rule promotes safety by holding generic drug manufacturers accountable
  • Delay will only lead to more Americans being hurt

Quinolone Vigilance Foundation and Ms. Brummert are honored to have been asked to participate in this project. During Ms. Brummert's testimonies, she will have the opportunity to speak on behalf of victims who have shared their stories with her.

Thursday, March 5, 2015

CBS Los Angeles airs news story






CBS Los Angeles aired a news story on March 5, 2015 during their 11PM broadcast. Featured is Southland firefighter Chris Jones who did a wonderful job.



Quinolone Vigilance Foundation wishes to thank Chris Jones for telling his story, and CBS Los Angeles for mentioning that in addition to Cipro, Levaquin and Avelox are included in this class of drugs and that they all cause horrific adverse reactions. QVF is linked at the bottom of the story.

Wednesday, March 4, 2015

QVF honors Mark O'Connor and Lincoln Combs


Quinolone Vigilance Foundation honors attorneys Mark O'Connor and Lincoln Combs from Gallagher and Kennedy Law Firm for their dedication and hard work on behalf of the fluoroquinolone community.





We also thank Gallagher & Kennedy Law Firm for displaying QVF awareness materials in their office.